SynthesisJournal of Parkinson's disease2025
Motor features that distinguish isolated REM sleep behavior disorder patients from healthy controls: A systematic review.
Synthesis in Journal of Parkinson's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Wearable Movement-Tracking for Prodromal Parkinson's Disease Detection: A Cross-Country Validation Study.Movement disorders : official journal of the Movement Disorder Society · 2026Article
- Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker-Defined Synucleinopathy.Annals of clinical and translational neurology · 2026Article
- Digital Technology for Sleep Symptoms in Parkinson's Disease: A Scoping Review.Journal of movement disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Individuals with isolated REM sleep behavior disorder (iRBD) are at high risk of developing α-synucleinopathies, particularly Parkinson's disease (PD) and dementia with Lewy bodies (DLB). With the development of potential neuroprotective treatments for synucleinopathies, including PD, identifying clinical features that can allow for tracking subtle changes in prodromal disease and thereby monitoring risk of phenoconversion in iRBD is paramount. Subtle motor deficits have been suggested to be present in iRBD, making them potentially important clinical markers for predicting future phenoconversion. This review aims to summarize existing literature that has investigated differences in motor function between iRBD and healthy individuals, as well as progression of motor decline in iRBD. 39 eligible studies were included in this review. The results suggest that quantitative motor assessments may be more sensitive to motor impairments in this population than clinical scales. Moreover, dual-tasking tended to unmask subtle motor deficits in individuals with iRBD, particularly in gait, balance, and tapping assessments. Longitudinal studies demonstrate that motor function worsens over time in iRBD, with earliest signs of motor deficits and clear progression in tapping assessments in particular. Larger longitudinal studies that use quantitative methods of motor assessments are needed to better characterize motor progression in iRBD, and confirm the reliability of different motor markers for predicting phenoconversion of iRBD into PD and other synucleinopathies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.